The Hague, Netherlands, 11 June 2024: Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces… Read More »NEWS: Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures The Hague, Netherlands, 3 October 2023: Amber Implants, an innovative medical technology company developing next-generation implants… Read More »NEWS: Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
The Hague, Netherlands, May 31, 2023: Amber Implants has achieved a significant milestone by obtaining regulatory approval for our clinical study in Europe. This remarkable achievement… Read More »News: Amber Implants receives approval for First in Human study in Europe